Xerox Distributes Pro Rata Warrants to Enhance Shareholder Value and Accelerate Deleveraging
MWN-AI** Summary
Xerox Holdings Corporation (NASDAQ: XRX) has announced a pro rata distribution of warrants to purchase common stock, aimed at enhancing shareholder value and reducing debt. On February 12, 2026, eligible security holders, including common stock and certain convertible note holders as of the February 9, 2026 record date, will receive one warrant for every two shares held. This initiative is part of Xerox's strategic efforts to improve its balance sheet and liquidity, as stated by COO Louie Pastor.
The warrants will allow shareholders to purchase Xerox common stock at an exercise price of $8.00 per share, subject to anti-dilution adjustments. Shareholders can exercise warrants via cash or through designated outstanding debt securities before their expiration on February 11, 2028. Specific obligations of Xerox, such as 5.500% Senior Unsecured Notes due 2028 and others, are eligible for warrant exercises, aiming to streamline the exercise process and enhance accessibility.
Important conditions regarding the exercise mechanics include an early expiration price condition, wherein warrants may expire early if the volume-weighted average price (VWAP) of Xerox shares meets specified thresholds over consecutive trading days.
Xerox intends to list the warrants on the Nasdaq under the symbol XRXDW, contingent on regulatory approvals. This move underscores the company's ongoing commitment to create sustainable shareholder value, leveraging innovative financing strategies in response to favorable operating trends. Interested investors are encouraged to review additional details and FAQs available on the company's website.
For further information, investors and media can contact Xerox representatives directly.
MWN-AI** Analysis
Xerox Holdings Corporation's recent announcement of the pro-rata warrant distribution is a strategic move aimed at enhancing shareholder value while addressing its capital structure challenges. By issuing warrants to its common stockholders and certain convertible securities holders, Xerox is inviting its investors to engage directly in future growth opportunities, potentially leveraging a more favorable equity structure.
For investors, this warrants distribution represents both an opportunity and a call for prudent analysis. Each Warrant, priced at an exercise cost of $8.00 per share, allows stakeholders to purchase shares at a predetermined price, which could benefit those who anticipate a future uptick in Xerox’s stock price. Given that the Warrants are set to expire on February 11, 2028, with specific conditions that could lead to early expiration, stakeholders should closely monitor the stock’s performance relative to these terms.
As Xerox continues to emphasize deleveraging alongside improving operational efficiencies, investors should consider the implications of this move in conjunction with broader market conditions. The Warrants represent a dual structure; channeled either through cash or via designated outstanding debt securities. This flexibility allows for a potential reduction in capital outflow, appealing to bondholders who also wish to capitalize on equity upside.
Moreover, shareholder sentiment and market perceptions will play crucial roles in the success of this initiative. Investors should remain informed about underlying business strategies post-acquisition of Lexmark and the anticipated operational efficiencies that could arise.
In navigating this unfolding scenario, analysts recommend that investors evaluate Xerox’s cash flow generation capabilities and overall market conditions to gauge the potential effectiveness of the Warrant exercise. A clear understanding of these dynamics will be essential for maximizing returns amidst the evolving corporate landscape.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Xerox Holdings Corporation (NASDAQ: XRX) (“Xerox” or the “Company”) today announced the distribution of warrants to purchase shares of Xerox common stock (the “Warrants”), to its eligible securityholders on February 12, 2026 (the “Distribution Date”), in accordance with its previously announced pro rata warrant distribution.
As previously announced, holders of record of Xerox common stock as of February 9, 2026 (the “Record Date”) received one (1) Warrant for every two (2) shares of Xerox common stock held, rounded down to the nearest whole Warrant. Holders of record of Xerox’s 3.75% Convertible Senior Notes due 2030 and Series A Convertible Perpetual Voting Preferred Stock as of the Record Date also received Warrants on a pass-through basis in accordance with the terms governing such securities.
“This action is part of a deliberate sequence of steps we are taking to leverage fit-for-purpose financing structures and instruments designed to strengthen our balance sheet and improve our capital structure in support of our long-term objective of creating sustainable shareholder value,” said Louie Pastor, president and chief operating officer at Xerox. “The pro-rata warrant distribution reinforces our focus on enhancing liquidity and accelerating deleveraging as we continue to see improving operating trends and integration progress.”
Warrant Terms
Eligibility: Holders of record of Xerox common stock as of February 9, 2026 (the “Record Date”) are eligible to receive Warrants. Holders of Xerox’s Series A Convertible Perpetual Voting Preferred Stock and 3.75% Convertible Senior Notes due 2030 as of the Record Date were also eligible to receive Warrants on a pass-through basis in accordance with the terms governing such securities. Investors should contact their brokers with any questions regarding their holder status.
Distribution Ratio: One (1) Warrant for every two (2) shares of Xerox common stock held as of the Record Date, rounded down to the nearest whole Warrant. No fractional Warrants were issued.
Exercise Price: $8.00 per share of Xerox common stock, subject to certain anti-dilution adjustments and/or amendments as provided in the warrant agreement.
Exercise Methods:
- With cash, at any time prior to expiration of the Warrants, and
- Using designated outstanding Xerox debt securities at any time prior to the earlier of the expiration of the Warrants and the Bond Exercise Termination (as defined below).
For purposes of exercise using debt securities, a specified principal amount of designated Xerox debt securities will be deemed to satisfy the applicable warrant exercise price, as set forth in the warrant agreement.
The following Xerox debt securities are initially designated as eligible for exercise of the Warrants:
- 5.500% Senior Unsecured Notes due 2028;
- 8.875% Senior Unsecured Notes due 2029;
- 3.750% Senior Unsecured Convertible Notes due 2030;
- 13.000% Step Up Senior Notes due 2030;
- 10.250% Senior Secured First Lien Notes due 2030;
- 13.500% Senior Secured Second Lien Notes due 2031;
- 4.800% Senior Unsecured Notes due 2035; and
- 6.750% Senior Unsecured Notes due 2039.
Designated Notes Exercise Mechanics : Xerox’s designated notes were issued in multiple authorized denominations, including $2,000, $1,000, and $1, which require different minimum delivery amounts to permit whole-warrant exercises and avoid fractional settlements. For designated notes with an authorized denomination of $2,000, delivery of one note entitles the Holder to exercise 250 Warrants for 250 shares of Xerox common stock, and for designated notes with an authorized denomination of $1,000, delivery of one note entitles the Holder to exercise 125 Warrants for 125 shares. Holders of designated notes with an authorized denomination of $1 must deliver a minimum of $8 in face value to exercise one Warrant for one share of Xerox common stock.
Expiration: The Warrants will expire at 5:00 p.m. New York City time on February 11, 2028, unless an early expiration price condition is triggered.
Notes Exercise Termination: The right to exercise Warrants using one or more series of designated debt securities will terminate if, during any period of thirty (30) consecutive trading days, there are at least twenty (20) trading days (whether or not consecutive) on which the volume-weighted average price (“VWAP”) of Xerox common stock equals or exceeds 50% of the then-applicable exercise price, as further described in the warrant agreement. Following the satisfaction of this condition, the Warrants will remain exercisable for cash in accordance with their terms. The Company may, at its discretion, redesignate certain or all debt securities as eligible for exercise under the warrant agreement.
Early Expiration Price Condition: The Early Expiration Price Condition will be satisfied if, during any period of thirty (30) consecutive trading days, there are at least twenty (20) trading days (whether or not consecutive) on which the VWAP of Xerox common stock equals or exceeds 100% of the then-applicable exercise price. Upon satisfaction of this condition, the Warrants will expire at 5:00 p.m. New York City time on the business day immediately following such twentieth (20th) trading day, or such other date as the Company may elect in accordance with the warrant agreement.
Listing: Xerox has applied to list the Warrants for trading on Nasdaq under the symbol XRXDW, subject to applicable approvals.
Additional Information
Additional details regarding the warrant distribution, including key dates, designated debt securities, and exercise procedures, will be provided in the warrant agreement and related investor materials available in the Warrant Q&A section of the Company’s website.
Transaction Advisors
B. Dyson Capital Advisors is serving as an Exclusive Financial and Warrant Structuring Advisor to Xerox. Kirkland & Ellis LLP is serving as legal counsel to Xerox.
No Offer or Solicitation
This press release is for informational purposes only and shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
The issuance of the Warrants has not been registered under the Securities Act of 1933, as amended (the “Securities Act”), as the distribution of a warrant for no consideration does not constitute a sale of a security under Section 2(a)(3) of the Securities Act. A prospectus and Form 8-A registration statement describing the terms of the Warrants and the underlying Common Stock have been filed with the SEC and are available on the SEC’s website located at http://www.sec.gov . Holders should read the prospectus carefully, including the Risk Factors section included and incorporated by reference therein.
This press release contains a general summary of the Warrants. Please read the warrant agreement relating to the Warrants as it will contain important information about the terms of the Warrants.
Forward-Looking Statement
This press release contains statements which are not historical facts that are considered forward-looking statements under federal securities laws and may be identified by words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “potential,” “predicts,” “projects,” “seeks,” “should,” “will,” “would,”, “could,”, “can,” “should,” “targeting,” “projecting,” “driving,” “future,” “plan,” “predict,” “may” or words of similar meaning and include, but are not limited to, statements regarding the potential benefits of the warrant distribution. Forward-looking statements are not guarantees of future performance and the Company’s actual results may differ significantly from the results discussed in the forward-looking statements. These forward-looking statements speak only as of the date of this document or as of the date to which they refer, and we assume no obligation to update any forward-looking statements as a result of new information or future events or developments, except as required by law. Factors that might cause such differences include, but are not limited to, those discussed in the Company’s Securities and Exchange Commission filings, including the Company’s reports on Forms 10-K and 10-Q. The Company assumes no obligation to revise or update any forward-looking statements for any reason, except as required by law.
About Xerox Holdings Corporation (NASDAQ: XRX)
Xerox has been redefining the workplace experience for over a century. As a services-led, software-enabled company, we power today’s hybrid workplace through advanced print, digital, and AI-driven technologies. In 2025, Xerox acquired Lexmark - expanding our global footprint, strengthening service capabilities, and equipping us to deliver an even broader portfolio of workplace technologies to our clients. Today, we continue our legacy of innovation to deliver client-centric, digitally driven solutions that meet the needs of a global, distributed workforce. Whether in offices, classrooms, or hospitals, we help our clients thrive in a constantly evolving business landscape.
Xerox ® is a trademark of Xerox in the United States and/or other countries.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260212542833/en/
Media Contact:
Justin Capella, Xerox, +1-203-258-6535, Justin.Capella@xerox.com
Investor Contact:
Greg Stein, Xerox, +1-203-598-9080, Greg.Stein@xerox.com
FAQ**
How does the pro rata warrant distribution by Xerox Holdings Corporation (NASDAQ: XRX) aim to enhance liquidity and accelerate deleveraging for the company?
What are the implications for stockholders of Xerox Holdings Corporation (NASDAQ: XRX) regarding the exercise price of $8.00 per share for the newly distributed Warrants?
Can you explain the conditions under which the Warrants from Xerox Holdings Corporation (NASDAQ: XRX) could experience early expiration, and how that impacts investors?
What advantages do holders of designated debt securities gain when exercising Warrants from Xerox Holdings Corporation (NASDAQ: XRX) as opposed to using cash?
**MWN-AI FAQ is based on asking OpenAI questions about Xerox Holdings Corporation (NASDAQ: XRX).
NASDAQ: XRX
XRX Trading
2.73% G/L:
$1.7001 Last:
946,573 Volume:
$1.71 Open:



